PBD2B
MCID: PRX064
MIFTS: 20

Peroxisome Biogenesis Disorder 2b (PBD2B)

Categories: Endocrine diseases, Eye diseases, Fetal diseases, Genetic diseases, Liver diseases, Mental diseases, Metabolic diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Peroxisome Biogenesis Disorder 2b

MalaCards integrated aliases for Peroxisome Biogenesis Disorder 2b:

Name: Peroxisome Biogenesis Disorder 2b 58 76 13 74
Pbd2b 58 76

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive


HPO:

33
peroxisome biogenesis disorder 2b:
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Peroxisome Biogenesis Disorder 2b

OMIM : 58 The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012). For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539. Individuals with mutations in the PEX5 gene have cells of complementation group 2 (CG2). For information on the history of PBD complementation groups, see 214100. (202370)

MalaCards based summary : Peroxisome Biogenesis Disorder 2b, is also known as pbd2b. An important gene associated with Peroxisome Biogenesis Disorder 2b is PEX5 (Peroxisomal Biogenesis Factor 5). Affiliated tissues include eye, and related phenotypes are low-set ears and frontal bossing

UniProtKB/Swiss-Prot : 76 Peroxisome biogenesis disorder 2B: A peroxisome biogenesis disorder that includes neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD), two milder manifestations of the Zellweger disease spectrum. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy and vision impairment. Children with the NALD presentation may reach their teens, while patients with the IRD presentation may reach adulthood. The clinical conditions are often slowly progressive in particular with respect to loss of hearing and vision. The biochemical abnormalities include accumulation of phytanic acid, very long chain fatty acids (VLCFA), di- and trihydroxycholestanoic acid and pipecolic acid.

Symptoms & Phenotypes for Peroxisome Biogenesis Disorder 2b

Human phenotypes related to Peroxisome Biogenesis Disorder 2b:

33 (show all 17)
# Description HPO Frequency HPO Source Accession
1 low-set ears 33 HP:0000369
2 frontal bossing 33 HP:0002007
3 high palate 33 HP:0000218
4 intellectual disability 33 HP:0001249
5 seizures 33 HP:0001250
6 wide nasal bridge 33 HP:0000431
7 abnormal facial shape 33 HP:0001999
8 anteverted nares 33 HP:0000463
9 prominent forehead 33 HP:0011220
10 epicanthus 33 HP:0000286
11 dolichocephaly 33 HP:0000268
12 high, narrow palate 33 HP:0002705
13 high forehead 33 HP:0000348
14 adrenal insufficiency 33 HP:0000846
15 esotropia 33 HP:0000565
16 elevated circulating long chain fatty acid concentration 33 HP:0003455
17 polar cataract 33 HP:0010696

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Ears:
low-set ears

Head And Neck Head:
prominent forehead
dolichocephaly
high forehead

Head And Neck Eyes:
esotropia
epicanthal folds
cataracts, neonatal polar

Head And Neck Face:
peculiar facies

Laboratory Abnormalities:
elevated long chain fatty acids caused by mutation in the peroxisome biogenesis factor 5 gene (pex5, )

Neurologic Central Nervous System:
seizures
mental retardation

Endocrine Features:
adrenal insufficiency

Head And Neck Nose:
anteverted nostrils
nasal bridge broad

Head And Neck Mouth:
palate high-arched

Clinical features from OMIM:

202370

Drugs & Therapeutics for Peroxisome Biogenesis Disorder 2b

Search Clinical Trials , NIH Clinical Center for Peroxisome Biogenesis Disorder 2b

Genetic Tests for Peroxisome Biogenesis Disorder 2b

Anatomical Context for Peroxisome Biogenesis Disorder 2b

MalaCards organs/tissues related to Peroxisome Biogenesis Disorder 2b:

42
Eye

Publications for Peroxisome Biogenesis Disorder 2b

Articles related to Peroxisome Biogenesis Disorder 2b:

# Title Authors Year
1
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. ( 7719337 )
1995

Variations for Peroxisome Biogenesis Disorder 2b

UniProtKB/Swiss-Prot genetic disease variations for Peroxisome Biogenesis Disorder 2b:

76
# Symbol AA change Variation ID SNP ID
1 PEX5 p.Asn526Lys VAR_007543 rs61752138
2 PEX5 p.Ser600Trp VAR_031328

ClinVar genetic disease variations for Peroxisome Biogenesis Disorder 2b:

6 (show all 12)
# Gene Variation Type Significance SNP ID Assembly Location
1 PEX5 NM_001131025.1(PEX5): c.1578T> G (p.Asn526Lys) single nucleotide variant Pathogenic rs61752138 GRCh37 Chromosome 12, 7362296: 7362296
2 PEX5 NM_001131025.1(PEX5): c.1578T> G (p.Asn526Lys) single nucleotide variant Pathogenic rs61752138 GRCh38 Chromosome 12, 7209700: 7209700
3 PEX5 NM_001131025.1(PEX5): c.1814G> A (p.Ser605Asn) single nucleotide variant Uncertain significance rs146567534 GRCh37 Chromosome 12, 7362713: 7362713
4 PEX5 NM_001131025.1(PEX5): c.1814G> A (p.Ser605Asn) single nucleotide variant Uncertain significance rs146567534 GRCh38 Chromosome 12, 7210117: 7210117
5 PEX5 NM_001131025.1(PEX5): c.815T> C (p.Met272Thr) single nucleotide variant Benign/Likely benign rs76708142 GRCh37 Chromosome 12, 7355269: 7355269
6 PEX5 NM_001131025.1(PEX5): c.815T> C (p.Met272Thr) single nucleotide variant Benign/Likely benign rs76708142 GRCh38 Chromosome 12, 7202673: 7202673
7 PEX5 NM_000319.4(PEX5): c.449-2A> G single nucleotide variant Pathogenic rs1555176945 GRCh37 Chromosome 12, 7351605: 7351605
8 PEX5 NM_000319.4(PEX5): c.449-2A> G single nucleotide variant Pathogenic rs1555176945 GRCh38 Chromosome 12, 7199009: 7199009
9 PEX5 NM_001131025.1(PEX5): c.1636C> T (p.Arg546Cys) single nucleotide variant Uncertain significance GRCh37 Chromosome 12, 7362354: 7362354
10 PEX5 NM_001131025.1(PEX5): c.1636C> T (p.Arg546Cys) single nucleotide variant Uncertain significance GRCh38 Chromosome 12, 7209758: 7209758
11 PEX5 NM_001131025.1(PEX5): c.164G> T (p.Gly55Val) single nucleotide variant Uncertain significance GRCh38 Chromosome 12, 7190904: 7190904
12 PEX5 NM_001131025.1(PEX5): c.164G> T (p.Gly55Val) single nucleotide variant Uncertain significance GRCh37 Chromosome 12, 7343500: 7343500

Expression for Peroxisome Biogenesis Disorder 2b

Search GEO for disease gene expression data for Peroxisome Biogenesis Disorder 2b.

Pathways for Peroxisome Biogenesis Disorder 2b

GO Terms for Peroxisome Biogenesis Disorder 2b

Sources for Peroxisome Biogenesis Disorder 2b

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....